speb/financial-data huggingface dataset:
BRNS balance_sheet (annual, 2022-12-31) — Tangible Book Value: 202418000.00
BRNS income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
BRNS income_statement (annual, 2022-12-31) — Tax Provision: -4471000.00
BRNS income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.21
BRNS balance_sheet (annual, 2022-12-31) — Taxes Receivable: 0.00
BRNS balance_sheet (annual, 2022-12-31) — Total Assets: 270205000.00
BRNS balance_sheet (annual, 2022-12-31) — Total Capitalization: 242896000.00
BRNS balance_sheet (annual, 2022-12-31) — Total Debt: 8773000.00
BRNS balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 243201000.00
BRNS income_statement (annual, 2022-12-31) — Total Expenses: 47504000.00
BRNS balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 27004000.00
BRNS balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 57164000.00
BRNS balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 14762000.00
BRNS income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -4041000.00
BRNS income_statement (annual, 2022-12-31) — Total Unusual Items: 0.00
BRNS income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 0.00
BRNS balance_sheet (annual, 2022-12-31) — Working Capital: 200799000.00
BRNS income_statement (annual, 2023-12-31) — +Operating Expense: 81255000.00
BRNS income_statement (annual, 2023-12-31) — +Total Revenue: 802000.00
BRNS balance_sheet (annual, 2023-12-31) — Accounts Payable: 1601000.00
BRNS balance_sheet (annual, 2023-12-31) — Accounts Receivable: 0.00
BRNS balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -3688000.00
BRNS balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 386602000.00
BRNS cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 0.00
BRNS income_statement (annual, 2023-12-31) — Basic Average Shares: 38386491.00
BRNS income_statement (annual, 2023-12-31) — Basic EPS: -1.91
BRNS cash_flow (annual, 2023-12-31) — Beginning Cash Position: 194385000.00
BRNS cash_flow (annual, 2023-12-31) — Capital Expenditure: -5413000.00
BRNS balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 12976000.00
BRNS balance_sheet (annual, 2023-12-31) — Capital Stock: 1000.00
BRNS balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 142090000.00
BRNS balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 142090000.00
BRNS cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 1872000.00
BRNS cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -5413000.00
BRNS cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -50925000.00
BRNS cash_flow (annual, 2023-12-31) — Change In Account Payable: -3378000.00
BRNS cash_flow (annual, 2023-12-31) — Change In Accrued Expense: 1993000.00
BRNS cash_flow (annual, 2023-12-31) — Change In Other Current Assets: 128000.00
BRNS cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -445000.00
BRNS cash_flow (annual, 2023-12-31) — Change In Payable: -3378000.00
BRNS cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -1385000.00
BRNS cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: 2200000.00
BRNS cash_flow (annual, 2023-12-31) — Change In Receivables: 5673000.00
BRNS cash_flow (annual, 2023-12-31) — Change In Working Capital: 6171000.00
BRNS cash_flow (annual, 2023-12-31) — Changes In Account Receivables: 5800000.00
BRNS cash_flow (annual, 2023-12-31) — Changes In Cash: -54466000.00
BRNS balance_sheet (annual, 2023-12-31) — Common Stock: 1000.00
BRNS balance_sheet (annual, 2023-12-31) — Common Stock Equity: 186784000.00
BRNS cash_flow (annual, 2023-12-31) — Common Stock Issuance: 2035000.00
BRNS balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 6800000.00
BRNS balance_sheet (annual, 2023-12-31) — Current Assets: 156905000.00
BRNS balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 1785000.00
BRNS balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 1785000.00
BRNS balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 0.00
BRNS balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 0.00
BRNS balance_sheet (annual, 2023-12-31) — Current Liabilities: 12598000.00
BRNS cash_flow (annual, 2023-12-31) — Deferred Income Tax: -3075000.00
BRNS cash_flow (annual, 2023-12-31) — Deferred Tax: -3075000.00
BRNS cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 5429000.00
BRNS cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 5429000.00
BRNS income_statement (annual, 2023-12-31) — Diluted Average Shares: 38386491.00
BRNS income_statement (annual, 2023-12-31) — Diluted EPS: -1.91
BRNS income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -73347000.00
BRNS income_statement (annual, 2023-12-31) — EBIT: -76494000.00
BRNS income_statement (annual, 2023-12-31) — EBITDA: -71065000.00
BRNS cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 2171000.00
BRNS cash_flow (annual, 2023-12-31) — End Cash Position: 142090000.00
BRNS cash_flow (annual, 2023-12-31) — Financing Cash Flow: 1872000.00
BRNS balance_sheet (annual, 2023-12-31) — Foreign Currency Translation Adjustments: -23315000.00
BRNS cash_flow (annual, 2023-12-31) — Free Cash Flow: -56338000.00
BRNS cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: 0.00
BRNS balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -23315000.00
BRNS income_statement (annual, 2023-12-31) — General And Administrative Expense: 39842000.00
BRNS balance_sheet (annual, 2023-12-31) — Goodwill: 12209000.00
BRNS balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 37317000.00
BRNS balance_sheet (annual, 2023-12-31) — Gross PPE: 23090000.00
BRNS income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 0.00
BRNS cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 0.00
BRNS income_statement (annual, 2023-12-31) — Interest Expense: 28000.00
BRNS income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 28000.00
BRNS income_statement (annual, 2023-12-31) — Interest Income: 2877000.00
BRNS income_statement (annual, 2023-12-31) — Interest Income Non Operating: 2877000.00
BRNS cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 0.00
BRNS balance_sheet (annual, 2023-12-31) — Invested Capital: 186784000.00
BRNS cash_flow (annual, 2023-12-31) — Investing Cash Flow: -5413000.00
BRNS cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 2035000.00
BRNS balance_sheet (annual, 2023-12-31) — Leases: 8673000.00
BRNS balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 11191000.00
BRNS balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 11191000.00
BRNS cash_flow (annual, 2023-12-31) — Long Term Debt Payments: 0.00
BRNS balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 1108000.00
BRNS balance_sheet (annual, 2023-12-31) — Minority Interest: 211000.00
BRNS income_statement (annual, 2023-12-31) — Minority Interests: 100000.00
BRNS cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 2035000.00
BRNS cash_flow (annual, 2023-12-31) — Net Foreign Currency Exchange Gain Loss: 7531000.00
BRNS income_statement (annual, 2023-12-31) — Net Income: -73347000.00
BRNS income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -73347000.00
BRNS income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -73447000.00
BRNS income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -73347000.00
BRNS income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -73347000.00
BRNS cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -73447000.00
BRNS income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -73447000.00
BRNS income_statement (annual, 2023-12-31) — Net Interest Income: 2849000.00
BRNS cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 0.00
BRNS cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 0.00
BRNS income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 2849000.00
BRNS cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -163000.00
BRNS balance_sheet (annual, 2023-12-31) — Net PPE: 19402000.00
BRNS cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -5413000.00
BRNS balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 149467000.00
BRNS balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 574000.00
BRNS balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 574000.00
BRNS income_statement (annual, 2023-12-31) — Normalized EBITDA: -71065000.00
BRNS income_statement (annual, 2023-12-31) — Normalized Income: -73347000.00
BRNS cash_flow (annual, 2023-12-31) — Operating Cash Flow: -50925000.00
BRNS cash_flow (annual, 2023-12-31) — Operating Gains Losses: 7531000.00
BRNS income_statement (annual, 2023-12-31) — Operating Income: -80453000.00
BRNS income_statement (annual, 2023-12-31) — Operating Revenue: 802000.00
BRNS balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 38643540.00
BRNS balance_sheet (annual, 2023-12-31) — Other Current Assets: 1474000.00
BRNS balance_sheet (annual, 2023-12-31) — Other Equity Interest: 86000.00
BRNS income_statement (annual, 2023-12-31) — Other Gand A: 39842000.00
BRNS income_statement (annual, 2023-12-31) — Other Income Expense: 1082000.00
BRNS balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 25108000.00
BRNS cash_flow (annual, 2023-12-31) — Other Non Cash Items: 1411000.00
BRNS balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 882000.00
BRNS balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 3148000.00
BRNS income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 1082000.00
BRNS balance_sheet (annual, 2023-12-31) — Other Properties: 13309000.00
BRNS balance_sheet (annual, 2023-12-31) — Other Receivables: 10310000.00
BRNS balance_sheet (annual, 2023-12-31) — Payables: 1601000.00
BRNS balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 8401000.00
BRNS balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 2412000.00
BRNS income_statement (annual, 2023-12-31) — Pretax Income: -76522000.00
BRNS cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 0.00
BRNS balance_sheet (annual, 2023-12-31) — Properties: 0.00
BRNS cash_flow (annual, 2023-12-31) — Purchase Of PPE: -5413000.00
BRNS balance_sheet (annual, 2023-12-31) — Receivables: 13341000.00
BRNS income_statement (annual, 2023-12-31) — Reconciled Depreciation: 5429000.00
BRNS cash_flow (annual, 2023-12-31) — Repayment Of Debt: 0.00
BRNS income_statement (annual, 2023-12-31) — Research And Development: 41413000.00
BRNS balance_sheet (annual, 2023-12-31) — Restricted Cash: 0.00
BRNS balance_sheet (annual, 2023-12-31) — Retained Earnings: -176590000.00
BRNS cash_flow (annual, 2023-12-31) — Sale Of PPE: 0.00
BRNS income_statement (annual, 2023-12-31) — Selling General And Administration: 39842000.00
BRNS balance_sheet (annual, 2023-12-31) — Share Issued: 38643540.00
BRNS income_statement (annual, 2023-12-31) — Special Income Charges: 0.00
BRNS cash_flow (annual, 2023-12-31) — Stock Based Compensation: 5055000.00
BRNS balance_sheet (annual, 2023-12-31) — Stockholders Equity: 186784000.00
BRNS balance_sheet (annual, 2023-12-31) — Tangible Book Value: 149467000.00
BRNS income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
BRNS income_statement (annual, 2023-12-31) — Tax Provision: -3075000.00
BRNS income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.04
BRNS balance_sheet (annual, 2023-12-31) — Taxes Receivable: 3031000.00
BRNS balance_sheet (annual, 2023-12-31) — Total Assets: 214506000.00
BRNS balance_sheet (annual, 2023-12-31) — Total Capitalization: 186784000.00
BRNS balance_sheet (annual, 2023-12-31) — Total Debt: 12976000.00
BRNS balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 186995000.00
BRNS income_statement (annual, 2023-12-31) — Total Expenses: 81255000.00
BRNS balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 27511000.00
BRNS balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 57601000.00
BRNS balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 14913000.00
BRNS income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -83914000.00
BRNS balance_sheet (annual, 2023-12-31) — Total Tax Payable: 0.00
BRNS income_statement (annual, 2023-12-31) — Total Unusual Items: 0.00
BRNS income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 0.00
BRNS balance_sheet (annual, 2023-12-31) — Working Capital: 144307000.00
BRNS income_statement (quarterly, 2024-09-30) — Basic Average Shares: 39419447.00
BRNS income_statement (quarterly, 2024-09-30) — Basic EPS: -0.21
BRNS cash_flow (quarterly, 2024-09-30) — Capital Expenditure: -114000.00
BRNS cash_flow (quarterly, 2024-09-30) — Change In Other Current Assets: 0.00
BRNS income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 39419447.00
BRNS income_statement (quarterly, 2024-09-30) — Diluted EPS: -0.21
BRNS balance_sheet (quarterly, 2024-09-30) — Goodwill: 12209000.00
BRNS income_statement (quarterly, 2024-09-30) — Impairment Of Capital Assets: 0.00
BRNS income_statement (quarterly, 2024-09-30) — Special Income Charges: 0.00
BRNS income_statement (quarterly, 2024-09-30) — Total Unusual Items: 0.00
BRNS income_statement (quarterly, 2024-09-30) — Total Unusual Items Excluding Goodwill: 0.00
BRNS income_statement (annual, 2024-12-31) — +Operating Expense: 66747000.00
BRNS income_statement (annual, 2024-12-31) — +Total Revenue: 14969000.00
BRNS balance_sheet (annual, 2024-12-31) — Accounts Payable: 2474000.00
BRNS balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -9420000.00
BRNS balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -9420000.00
BRNS balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 393474000.00
BRNS cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 17469000.00
BRNS income_statement (annual, 2024-12-31) — Basic Average Shares: 39348240.00
BRNS income_statement (annual, 2024-12-31) — Basic EPS: -1.55
BRNS cash_flow (annual, 2024-12-31) — Beginning Cash Position: 142090000.00
BRNS cash_flow (annual, 2024-12-31) — Capital Expenditure: -892000.00
BRNS cash_flow (quarterly, 2024-12-31) — Capital Expenditure: -278000.00
BRNS balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 12007000.00
BRNS balance_sheet (annual, 2024-12-31) — Capital Stock: 1000.00
BRNS balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 110662000.00
BRNS balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 110662000.00
BRNS cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 2163000.00
BRNS cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -892000.00
BRNS cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -28940000.00
BRNS cash_flow (annual, 2024-12-31) — Change In Account Payable: 898000.00
BRNS cash_flow (annual, 2024-12-31) — Change In Accrued Expense: 456000.00
BRNS cash_flow (annual, 2024-12-31) — Change In Other Current Assets: 0.00
BRNS cash_flow (quarterly, 2024-12-31) — Change In Other Current Assets: 0.00
BRNS cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -1789000.00
BRNS cash_flow (annual, 2024-12-31) — Change In Other Working Capital: 1738000.00
BRNS cash_flow (annual, 2024-12-31) — Change In Payable: 898000.00
BRNS cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 1354000.00
BRNS cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: 3643000.00
BRNS cash_flow (annual, 2024-12-31) — Change In Receivables: -2345000.00
BRNS cash_flow (annual, 2024-12-31) — Change In Working Capital: 2601000.00
BRNS cash_flow (annual, 2024-12-31) — Changes In Account Receivables: 0.00
BRNS cash_flow (annual, 2024-12-31) — Changes In Cash: -27669000.00
BRNS balance_sheet (annual, 2024-12-31) — Common Stock: 1000.00
BRNS balance_sheet (annual, 2024-12-31) — Common Stock Equity: 130029000.00
BRNS cash_flow (annual, 2024-12-31) — Common Stock Issuance: 2163000.00
BRNS cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: 837000.00
BRNS balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 5335000.00
BRNS balance_sheet (annual, 2024-12-31) — Current Assets: 125742000.00
BRNS balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 1920000.00
BRNS balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 1920000.00
BRNS balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 1738000.00
BRNS balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 1738000.00
BRNS balance_sheet (annual, 2024-12-31) — Current Liabilities: 15657000.00
BRNS cash_flow (annual, 2024-12-31) — Deferred Income Tax: -44000.00
BRNS cash_flow (annual, 2024-12-31) — Deferred Tax: -44000.00
BRNS cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 5800000.00
BRNS cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 5800000.00
BRNS income_statement (annual, 2024-12-31) — Diluted Average Shares: 39348240.00
BRNS income_statement (annual, 2024-12-31) — Diluted EPS: -1.55
BRNS income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -61074000.00
BRNS income_statement (annual, 2024-12-31) — EBIT: -61174000.00
BRNS income_statement (annual, 2024-12-31) — EBITDA: -55374000.00
BRNS cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -2021000.00
BRNS cash_flow (annual, 2024-12-31) — End Cash Position: 112400000.00
BRNS cash_flow (annual, 2024-12-31) — Financing Cash Flow: 2163000.00
BRNS balance_sheet (annual, 2024-12-31) — Foreign Currency Translation Adjustments: -25868000.00
BRNS cash_flow (annual, 2024-12-31) — Free Cash Flow: -29832000.00
BRNS cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: 0.00
BRNS balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -25868000.00
BRNS income_statement (annual, 2024-12-31) — General And Administrative Expense: 29670000.00
BRNS balance_sheet (annual, 2024-12-31) — Goodwill: 0.00
BRNS balance_sheet (quarterly, 2024-12-31) — Goodwill: 0.00
BRNS balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 21947000.00
BRNS balance_sheet (annual, 2024-12-31) — Gross PPE: 21177000.00
BRNS income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 12209000.00
BRNS income_statement (annual, 2024-12-31) — Interest Expense: 53000.00
BRNS income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 53000.00
BRNS income_statement (annual, 2024-12-31) — Interest Income: 2678000.00
BRNS income_statement (annual, 2024-12-31) — Interest Income Non Operating: 2678000.00
BRNS balance_sheet (annual, 2024-12-31) — Invested Capital: 130029000.00
BRNS cash_flow (annual, 2024-12-31) — Investing Cash Flow: -892000.00
BRNS cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 2163000.00
BRNS cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: 837000.00
BRNS balance_sheet (annual, 2024-12-31) — Leases: 9282000.00
BRNS balance_sheet (quarterly, 2024-12-31) — Leases: 9282000.00
BRNS balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 10087000.00
BRNS balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 10087000.00
BRNS balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 1333000.00
BRNS balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 1333000.00
BRNS balance_sheet (annual, 2024-12-31) — Minority Interest: 106000.00
BRNS income_statement (annual, 2024-12-31) — Minority Interests: 109000.00
BRNS cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 2163000.00
BRNS cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: 837000.00
BRNS cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: -649000.00
BRNS income_statement (annual, 2024-12-31) — Net Income: -61074000.00
BRNS income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -61074000.00
BRNS income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -61183000.00
BRNS income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -61074000.00
BRNS income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -61074000.00
BRNS cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -61183000.00
BRNS income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -61183000.00
BRNS income_statement (annual, 2024-12-31) — Net Interest Income: 2625000.00
BRNS income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 2625000.00
BRNS balance_sheet (annual, 2024-12-31) — Net PPE: 11757000.00
BRNS cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -892000.00
BRNS balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 108082000.00
BRNS balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 438000.00
BRNS balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 438000.00
BRNS income_statement (annual, 2024-12-31) — Normalized EBITDA: -43165000.00
BRNS income_statement (annual, 2024-12-31) — Normalized Income: -48873546.30
BRNS cash_flow (annual, 2024-12-31) — Operating Cash Flow: -28940000.00
BRNS cash_flow (annual, 2024-12-31) — Operating Gains Losses: -649000.00
BRNS income_statement (annual, 2024-12-31) — Operating Income: -51778000.00
BRNS income_statement (annual, 2024-12-31) — Operating Revenue: 14969000.00
BRNS balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 40234663.00
BRNS balance_sheet (annual, 2024-12-31) — Other Current Assets: 344000.00
BRNS balance_sheet (annual, 2024-12-31) — Other Equity Interest: 86000.00
BRNS income_statement (annual, 2024-12-31) — Other Gand A: 29670000.00
BRNS income_statement (annual, 2024-12-31) — Other Income Expense: -12074000.00
BRNS balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 21947000.00
BRNS balance_sheet (quarterly, 2024-12-31) — Other Intangible Assets: 21947000.00
BRNS cash_flow (annual, 2024-12-31) — Other Non Cash Items: 2357000.00
BRNS balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 881000.00
BRNS balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 4010000.00
BRNS income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 135000.00
BRNS income_statement (annual, 2024-12-31) — Other Operating Expenses: -1176000.00
BRNS balance_sheet (annual, 2024-12-31) — Other Properties: 10562000.00
BRNS balance_sheet (annual, 2024-12-31) — Other Receivables: 7139000.00
BRNS balance_sheet (annual, 2024-12-31) — Payables: 4890000.00
BRNS balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 10225000.00
BRNS balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 1774000.00
BRNS balance_sheet (annual, 2024-12-31) — Prepaid Assets: 5859000.00
BRNS income_statement (annual, 2024-12-31) — Pretax Income: -61227000.00
BRNS cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 0.00
BRNS balance_sheet (annual, 2024-12-31) — Properties: 0.00
BRNS balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
BRNS cash_flow (annual, 2024-12-31) — Purchase Of PPE: -892000.00
BRNS balance_sheet (annual, 2024-12-31) — Receivables: 7139000.00
BRNS income_statement (annual, 2024-12-31) — Reconciled Depreciation: 5800000.00
BRNS income_statement (annual, 2024-12-31) — Research And Development: 38253000.00
BRNS balance_sheet (annual, 2024-12-31) — Restricted Cash: 1738000.00
BRNS balance_sheet (annual, 2024-12-31) — Retained Earnings: -237664000.00
BRNS cash_flow (annual, 2024-12-31) — Sale Of PPE: 0.00
BRNS income_statement (annual, 2024-12-31) — Selling General And Administration: 29670000.00
BRNS balance_sheet (annual, 2024-12-31) — Share Issued: 40234663.00
BRNS income_statement (annual, 2024-12-31) — Special Income Charges: -12209000.00
BRNS cash_flow (annual, 2024-12-31) — Stock Based Compensation: 4709000.00
BRNS balance_sheet (annual, 2024-12-31) — Stockholders Equity: 130029000.00
BRNS balance_sheet (annual, 2024-12-31) — Tangible Book Value: 108082000.00
BRNS income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -8546.30
BRNS income_statement (annual, 2024-12-31) — Tax Provision: -44000.00
BRNS income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
BRNS balance_sheet (annual, 2024-12-31) — Taxes Receivable: 0.00
BRNS balance_sheet (annual, 2024-12-31) — Total Assets: 160327000.00
BRNS balance_sheet (annual, 2024-12-31) — Total Capitalization: 130029000.00
BRNS balance_sheet (annual, 2024-12-31) — Total Debt: 12007000.00
BRNS balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 130135000.00
BRNS income_statement (annual, 2024-12-31) — Total Expenses: 66747000.00
BRNS balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 30192000.00
BRNS balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 34585000.00
BRNS balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 14535000.00
BRNS income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -67970000.00
BRNS balance_sheet (annual, 2024-12-31) — Total Tax Payable: 2416000.00
BRNS balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 2416000.00
BRNS income_statement (annual, 2024-12-31) — Total Unusual Items: -12209000.00
BRNS income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -12209000.00
BRNS balance_sheet (annual, 2024-12-31) — Working Capital: 110085000.00
BRNS income_statement (quarterly, 2025-03-31) — +Operating Expense: 20298000.00
BRNS income_statement (quarterly, 2025-03-31) — +Total Revenue: 0.00
BRNS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 1357000.00
BRNS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 393944000.00
BRNS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 40265216.00
BRNS income_statement (quarterly, 2025-03-31) — Basic EPS: -0.49
BRNS cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 112400000.00
BRNS cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -5000.00
BRNS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 11919000.00
BRNS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 1000.00
BRNS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 99118000.00
BRNS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 99118000.00
BRNS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 2000.00
BRNS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -5000.00
BRNS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -14902000.00
BRNS cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -1155000.00
BRNS cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -2522000.00
BRNS cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -478000.00
BRNS cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -277000.00
BRNS cash_flow (quarterly, 2025-03-31) — Change In Payable: -1155000.00
BRNS cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -3677000.00
BRNS cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 48000.00
BRNS cash_flow (quarterly, 2025-03-31) — Change In Receivables: 4247000.00
BRNS cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -137000.00
BRNS cash_flow (quarterly, 2025-03-31) — Changes In Cash: -14905000.00
BRNS balance_sheet (quarterly, 2025-03-31) — Common Stock: 1000.00
BRNS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 115494000.00
BRNS cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 0.00
BRNS balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 6288000.00
BRNS balance_sheet (quarterly, 2025-03-31) — Current Assets: 109882000.00
BRNS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 1960000.00
BRNS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 1960000.00
BRNS balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 1461000.00
BRNS balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 1461000.00
BRNS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 11976000.00
BRNS cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: -22000.00
BRNS cash_flow (quarterly, 2025-03-31) — Deferred Tax: -22000.00
BRNS cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 2034000.00
BRNS cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 2034000.00
BRNS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 40265216.00
BRNS income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.49
BRNS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -19648000.00
BRNS income_statement (quarterly, 2025-03-31) — EBIT: -19667000.00
BRNS income_statement (quarterly, 2025-03-31) — EBITDA: -17633000.00
BRNS cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 3084000.00
BRNS cash_flow (quarterly, 2025-03-31) — End Cash Position: 100579000.00
BRNS cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 2000.00
BRNS balance_sheet (quarterly, 2025-03-31) — Foreign Currency Translation Adjustments: -21225000.00
BRNS cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -14907000.00
BRNS cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of PPE: 0.00
BRNS balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -21225000.00
BRNS income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 12639000.00
BRNS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 21156000.00
BRNS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 10056000.00
BRNS income_statement (quarterly, 2025-03-31) — Interest Expense: 13000.00
BRNS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 13000.00
BRNS income_statement (quarterly, 2025-03-31) — Interest Income: 556000.00
BRNS income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 556000.00
BRNS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 115494000.00
BRNS cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -5000.00
BRNS cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 0.00
BRNS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 9959000.00
BRNS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 9959000.00
BRNS balance_sheet (quarterly, 2025-03-31) — Minority Interest: 99000.00
BRNS income_statement (quarterly, 2025-03-31) — Minority Interests: 10000.00
BRNS cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
BRNS cash_flow (quarterly, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: 1587000.00
BRNS income_statement (quarterly, 2025-03-31) — Net Income: -19648000.00
BRNS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -19648000.00
BRNS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -19658000.00
BRNS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -19648000.00
BRNS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -19648000.00
BRNS cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -19658000.00
BRNS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -19658000.00
BRNS income_statement (quarterly, 2025-03-31) — Net Interest Income: 543000.00
BRNS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 543000.00
BRNS balance_sheet (quarterly, 2025-03-31) — Net PPE: 10056000.00
BRNS cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -5000.00
BRNS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 94338000.00
BRNS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 416000.00
BRNS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 416000.00
BRNS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -17633000.00
BRNS income_statement (quarterly, 2025-03-31) — Normalized Income: -19648000.00
BRNS cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -14902000.00
BRNS cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 1587000.00
BRNS income_statement (quarterly, 2025-03-31) — Operating Income: -20298000.00
BRNS income_statement (quarterly, 2025-03-31) — Operating Revenue: 0.00
BRNS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 40339395.00
BRNS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 435000.00
BRNS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 86000.00
BRNS income_statement (quarterly, 2025-03-31) — Other Gand A: 12639000.00
BRNS income_statement (quarterly, 2025-03-31) — Other Income Expense: 75000.00
BRNS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 21156000.00
BRNS cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 826000.00
BRNS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 902000.00
BRNS balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 4052000.00
BRNS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 75000.00
BRNS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: -329000.00
BRNS balance_sheet (quarterly, 2025-03-31) — Other Properties: 10056000.00
BRNS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 3326000.00
BRNS balance_sheet (quarterly, 2025-03-31) — Payables: 1357000.00
BRNS balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 7645000.00
BRNS balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 910000.00
BRNS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 5011000.00
BRNS income_statement (quarterly, 2025-03-31) — Pretax Income: -19680000.00
BRNS cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 2000.00
BRNS cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -5000.00
BRNS balance_sheet (quarterly, 2025-03-31) — Receivables: 3857000.00
BRNS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 2034000.00
BRNS income_statement (quarterly, 2025-03-31) — Research And Development: 7988000.00
BRNS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 1461000.00
BRNS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -257312000.00
BRNS cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 0.00
BRNS income_statement (quarterly, 2025-03-31) — Selling General And Administration: 12639000.00
BRNS balance_sheet (quarterly, 2025-03-31) — Share Issued: 40339395.00
BRNS cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 468000.00
BRNS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 115494000.00
BRNS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 94338000.00
BRNS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
BRNS income_statement (quarterly, 2025-03-31) — Tax Provision: -22000.00
BRNS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
BRNS balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 531000.00
BRNS balance_sheet (quarterly, 2025-03-31) — Total Assets: 141996000.00
BRNS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 115494000.00
BRNS balance_sheet (quarterly, 2025-03-31) — Total Debt: 11919000.00
BRNS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 115593000.00
BRNS income_statement (quarterly, 2025-03-31) — Total Expenses: 20298000.00
BRNS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 26403000.00
BRNS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 32114000.00
BRNS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 14427000.00
BRNS income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -20600000.00
BRNS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 0.00
BRNS balance_sheet (quarterly, 2025-03-31) — Working Capital: 97906000.00
BRNS income_statement (quarterly, 2025-06-30) — +Operating Expense: 21982000.00
BRNS income_statement (quarterly, 2025-06-30) — +Total Revenue: 0.00
BRNS balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 1800000.00
BRNS balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 393663000.00
BRNS balance_sheet (quarterly, 2025-06-30) — Assets Held For Sale Current: 413000.00
BRNS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 40343521.00
BRNS income_statement (quarterly, 2025-06-30) — Basic EPS: -0.52
BRNS cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 100579000.00
BRNS cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -32000.00
BRNS balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 11988000.00
BRNS balance_sheet (quarterly, 2025-06-30) — Capital Stock: 1000.00
BRNS balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 86259000.00
BRNS balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 86259000.00
BRNS cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 0.00
BRNS cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -32000.00
BRNS cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -18109000.00
BRNS cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 342000.00
BRNS cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: -245000.00
BRNS cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -495000.00
BRNS cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -65000.00
BRNS cash_flow (quarterly, 2025-06-30) — Change In Payable: 342000.00
BRNS cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 97000.00
BRNS cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -579000.00
BRNS cash_flow (quarterly, 2025-06-30) — Change In Receivables: -1156000.00
BRNS cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -2198000.00
BRNS cash_flow (quarterly, 2025-06-30) — Changes In Cash: -18141000.00
BRNS balance_sheet (quarterly, 2025-06-30) — Common Stock: 1000.00
BRNS balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 102377000.00
BRNS cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 0.00
BRNS balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 6255000.00
BRNS balance_sheet (quarterly, 2025-06-30) — Current Assets: 100414000.00
BRNS balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 2036000.00
BRNS balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 2036000.00
BRNS balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 1525000.00
BRNS balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 1525000.00
BRNS balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 12725000.00
BRNS cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: -25000.00
BRNS cash_flow (quarterly, 2025-06-30) — Deferred Tax: -25000.00
BRNS cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 2001000.00
BRNS cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 2001000.00
BRNS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 40343521.00
BRNS income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.52
BRNS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -21124000.00
BRNS income_statement (quarterly, 2025-06-30) — EBIT: -21139000.00
BRNS income_statement (quarterly, 2025-06-30) — EBITDA: -19138000.00
BRNS cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 5346000.00
BRNS cash_flow (quarterly, 2025-06-30) — End Cash Position: 87784000.00
BRNS cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 0.00
BRNS balance_sheet (quarterly, 2025-06-30) — Foreign Currency Translation Adjustments: -12937000.00
BRNS cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -18141000.00
BRNS cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of PPE: -281000.00
BRNS balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -12937000.00
BRNS income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 15384000.00
BRNS balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 20366000.00
BRNS balance_sheet (quarterly, 2025-06-30) — Gross PPE: 7837000.00
BRNS income_statement (quarterly, 2025-06-30) — Interest Expense: 12000.00
BRNS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 12000.00
BRNS income_statement (quarterly, 2025-06-30) — Interest Income: 523000.00
BRNS income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 523000.00
BRNS balance_sheet (quarterly, 2025-06-30) — Invested Capital: 102377000.00
BRNS cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -32000.00
BRNS cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 0.00
BRNS balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 9952000.00
BRNS balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 9952000.00
BRNS balance_sheet (quarterly, 2025-06-30) — Minority Interest: 104000.00
BRNS income_statement (quarterly, 2025-06-30) — Minority Interests: 2000.00
BRNS cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 0.00
BRNS cash_flow (quarterly, 2025-06-30) — Net Foreign Currency Exchange Gain Loss: 3282000.00
BRNS income_statement (quarterly, 2025-06-30) — Net Income: -21124000.00
BRNS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -21124000.00
BRNS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -21126000.00
BRNS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -21124000.00
BRNS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -21124000.00
BRNS cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -21126000.00
BRNS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -21126000.00
BRNS income_statement (quarterly, 2025-06-30) — Net Interest Income: 511000.00
BRNS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 511000.00
BRNS balance_sheet (quarterly, 2025-06-30) — Net PPE: 7837000.00
BRNS cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -32000.00
BRNS balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 82011000.00
BRNS balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 391000.00
BRNS balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 391000.00
BRNS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -19138000.00
BRNS income_statement (quarterly, 2025-06-30) — Normalized Income: -21124000.00
BRNS cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -18109000.00
BRNS cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 3001000.00
BRNS income_statement (quarterly, 2025-06-30) — Operating Income: -21982000.00
BRNS income_statement (quarterly, 2025-06-30) — Operating Revenue: 0.00
BRNS balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 40348665.00
BRNS balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 854000.00
BRNS balance_sheet (quarterly, 2025-06-30) — Other Equity Interest: 86000.00
BRNS income_statement (quarterly, 2025-06-30) — Other Gand A: 15384000.00
BRNS income_statement (quarterly, 2025-06-30) — Other Income Expense: 320000.00
BRNS balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 20366000.00
BRNS cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 519000.00
BRNS balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 944000.00
BRNS balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 4012000.00
BRNS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 320000.00
BRNS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: -13000.00
BRNS balance_sheet (quarterly, 2025-06-30) — Other Properties: 7837000.00
BRNS balance_sheet (quarterly, 2025-06-30) — Other Receivables: 4675000.00
BRNS balance_sheet (quarterly, 2025-06-30) — Payables: 1800000.00
BRNS balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 8055000.00
BRNS balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 1109000.00
BRNS balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 6350000.00
BRNS income_statement (quarterly, 2025-06-30) — Pretax Income: -21151000.00
BRNS cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 0.00
BRNS cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -32000.00
BRNS balance_sheet (quarterly, 2025-06-30) — Receivables: 5013000.00
BRNS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 2001000.00
BRNS income_statement (quarterly, 2025-06-30) — Research And Development: 6611000.00
BRNS balance_sheet (quarterly, 2025-06-30) — Restricted Cash: 1525000.00
BRNS balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -278436000.00
BRNS income_statement (quarterly, 2025-06-30) — Selling General And Administration: 15384000.00
BRNS balance_sheet (quarterly, 2025-06-30) — Share Issued: 40348665.00
BRNS cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: -281000.00
BRNS balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 102377000.00
BRNS balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 82011000.00
BRNS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
BRNS income_statement (quarterly, 2025-06-30) — Tax Provision: -25000.00
BRNS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
BRNS balance_sheet (quarterly, 2025-06-30) — Taxes Receivable: 338000.00
BRNS balance_sheet (quarterly, 2025-06-30) — Total Assets: 129561000.00
BRNS balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 102377000.00
BRNS balance_sheet (quarterly, 2025-06-30) — Total Debt: 11988000.00
BRNS balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 102481000.00
BRNS income_statement (quarterly, 2025-06-30) — Total Expenses: 21982000.00
BRNS balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 27080000.00
BRNS balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 29147000.00
BRNS balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 14355000.00
BRNS income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -23324000.00
BRNS balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 0.00
BRNS balance_sheet (quarterly, 2025-06-30) — Working Capital: 87689000.00
BRNS income_statement (quarterly, 2025-09-30) — +Operating Expense: 10159000.00
BRNS income_statement (quarterly, 2025-09-30) — +Total Revenue: 0.00
BRNS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 698000.00
BRNS balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 393248000.00
BRNS balance_sheet (quarterly, 2025-09-30) — Assets Held For Sale Current: 138000.00
BRNS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 40661118.00
BRNS income_statement (quarterly, 2025-09-30) — Basic EPS: -0.36
BRNS cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 87784000.00
BRNS balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 11570000.00
BRNS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 1000.00
BRNS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 74272000.00
BRNS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 74272000.00